Endogenous peptide
Human proinsulin C-peptide
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Human proinsulin C-peptide →Peptide directory
Find a peptide
Public profiles inside a larger governed registry
Search by peptide name, brand, or research code. Open a full evidence profile or the published sources available for a record still in development. Source publication does not mean a completed scientific appraisal.
The registry is an expanding catalog, not a complete list of every peptide. A missing public result does not mean no research exists.
Published profiles
Search profiles and sources
- Emerging
Humanin is a mitochondrial-derived peptide investigated in cellular stress and metabolic biology. Associations involving circulating humanin and experiments with related fragments do not establish a treatment in humans.
Evidence and record details
Evidence integrity map
Human 0Preclinical 1Durable IDs 6Open signals 1- Publication state
- Published profile
- Verified source records
- 326 source records verified
- Chemistry record
- Chemistry record on file
- Regulatory entries
- 2 published regulatory entries
- Research questions
- No open questions documented
- Evidence review date
- No documented human review recorded
Source verification checks records; it does not itself approve scientific conclusions.
Spider-venom peptide
Huwentoxin-IV
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Huwentoxin-IV →Venom-derived peptide toxin
Iberiotoxin
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Iberiotoxin →Bradykinin B2 receptor antagonist peptide
Icatibant
Published sources available; full evidence profile in development.
5 published source records. Source publication does not imply scientific appraisal.
Open sources for Icatibant →IGF-1 analog
IGF-1 LR3
Published sources available; full evidence profile in development.
5 published source records. Source publication does not imply scientific appraisal.
Open sources for IGF-1 LR3 →Antimicrobial peptide
Indolicidin
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Indolicidin →Endogenous glycoprotein hormone
Inhibin A
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Inhibin A →Endogenous glycoprotein hormone
Inhibin B
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Inhibin B →Peptide hormone
Insulin
Published sources available; full evidence profile in development.
6 published source records. Source publication does not imply scientific appraisal.
Open sources for Insulin →Insulin peptide chain
Insulin A chain
Published sources available; full evidence profile in development.
1 published source records. Source publication does not imply scientific appraisal.
Open sources for Insulin A chain →Insulin analog
Insulin aspart
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Insulin aspart →Insulin peptide chain
Insulin B chain
Published sources available; full evidence profile in development.
1 published source records. Source publication does not imply scientific appraisal.
Open sources for Insulin B chain →Insulin analog
Insulin degludec
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Insulin degludec →Insulin analog
Insulin detemir
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Insulin detemir →Long-acting insulin fusion protein
Insulin efsitora alfa
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Insulin efsitora alfa →Insulin analog
Insulin glargine
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Insulin glargine →Insulin analog
Insulin glulisine
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Insulin glulisine →
How the public directory relates to the 500-record Master Registry
master registry transparency
500 master records, with governance status shown explicitly
501
Master records
467
Governed records
34
Review-deferred
458
Peptide acquisition eligible
9
Governed comparators
The master registry has 467 governed identities from 501 records. 34 remain review-gated. Nine governed records are scientific comparators, leaving 458 peptide identities in the source acquisition cohort. Database reconciliation is a separate step. The 51 profiles shown on this directory are a represented public-profile subset, not the size of the master registry. All 51 public profiles on this render reconcile to governed peptide identities in that registry; unknown, duplicate, deferred, or comparator identities fail closed instead of appearing publicly.
Explore the full Master Registry →What the profile status labels mean
Evidence, chemistry, and regulatory counts include only records that crossed the relevant public-publication gate. A zero means none published in that lane—not that nothing is known. “No governed record published” is a publication-state disclosure; internal or pending material may exist without appearing in public counts. Source verification, editorial publication, and accountable scientific appraisal are distinct states; a source count alone does not approve a scientific conclusion.
Recently updated public records
When each public profile record was last changed — not clinical or scientific activity.